Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Precancerous Conditions 1Neoplasms, Second Primary 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Head and Neck Fibrosis 1Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Adenomatous Polyps 1

Interventions

Sildenafil Citrate 9Tadalafil 4Surveys and Questionnaires 2Pentoxifylline 2Alprostadil 2udenafil 1mirabegron 1methyl 3-mercaptopropionimidate 1bicalutamide 1alpha-Tocopherol 1Yoga 1Vitamin E 1Tamoxifen 1Tacrolimus 1Tablets 1Surgical Instruments 1Saline Solution 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Menogaril 1Long-Term Synaptic Depression 1Laparoscopy 1Intraoperative Neurophysiological Monitoring 1Indocyanine Green 1Holistic Health 1High-Intensity Focused Ultrasound Ablation 1GPI 1485 1Exercise 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Erectile Dysfunction × alpha-Tocopherol × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡